Tuesday, September 16, 2025
HomeNews

News

TrustPoint Announces Launch of First Commercially-Funded, Purpose-Built PNT Microsatellite

TrustPoint, an aerospace startup providing next-generation GNSS products and services, today announced the launch of its first satellite. The satellite, named "It’s About Time”,...

Authentix Completes Acquisition of Royal Joh. Enschedé Further Expanding Its Capabilities in Security Printing

Authentix, the authority in authentication and information services, announced that it has acquired Netherlands based Royal Joh. Enschedé, a leading specialty printing and security solutions provider from...

Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.

Merck, known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. announced that the companies have entered into a definitive agreement...

Merck’s KEYTRUDA Plus Chemotherapy Significantly Improved Overall Survival Compared to Chemotherapy Alone in Patients With Advanced or Unresectable Biliary Tract Cancer

Merck, known as MSD outside of the United States and Canada, announced results from the Phase 3 KEYNOTE-966 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy,...

Genentech’s Tecentriq Plus Avastin Reduced the Risk of Cancer Returning in People With Certain Types of Adjuvant Liver Cancer in a Phase III Study

Genentech, a member of the Roche Group, announced new data from the Phase III IMbrave050 study that show Tecentriq plus Avastin demonstrated a statistically significant...
0FansLike
0FollowersFollow
spot_img

Hot Topics